Department of Interventional Radiology, Pomeranian Medical University, 70-111 Szczecin, Poland.
Department of General and Dental Diagnostic Imaging, Pomeranian Medical University, 70-111 Szczecin, Poland.
Curr Oncol. 2021 Jun 20;28(3):2296-2307. doi: 10.3390/curroncol28030211.
Chemoembolization with irinotecan-loaded microspheres has proven effective in the treatment of unresectable liver metastases in the course of colorectal cancer (CRC). Most researchers recommend slowly administering the embolizate at the level of the lobar arteries, without obtaining visible stasis. However, there are reports of a relationship between postoperative embolizate retention in metastatic lesions and the response to treatment. To retain residual embolizate throughout the entire neoplastic lesion requires a temporary flow stop (stasis) within all supply vessels, which may cause temporary stasis in subsegmental or even segmental vessels.
To assess the risk of complications and post-embolization syndrome severity following chemoembolization of CRC metastatic liver lesions with microspheres loaded with Irinotecan, with regard to hepatic-artery branch level of temporary stasis.
The study included 52 patients (29 female, 23 male) with liver metastases from CRC, who underwent 202 chemoembolization treatments (mean: 3.88 per patient) with microspheres loaded with 100 mg irinotecan. Postembolization syndrome (PES) severity and complication occurrence were assessed with regard to the hepatic-artery branch level of temporary stasis. Adverse events were assessed according to Cancer Therapy Evaluation Program Common Terminology Criteria for Adverse Events.
Median survival from the start of chemoembolization was 13 months. From 202 chemoembolization sessions, 15 (7.4%) significant complications were found. The study found a significant relationship between the branch level of temporary stasis and the presence of complications ( < 0.001), with the highest number of complications observed with temporary stasis in segmental vessels. PES was diagnosed after 103 (51%) chemoembolization treatments. A significant association was found between PES severity and the branch level of temporary stasis ( < 0.001).
The branch level of temporary stasis affected the severity of post-embolization syndrome. A significant association was found between the branch level of temporary stasis obtained in chemoembolization procedures and the presence of complications. The apparent lack of change in numbers of complications when stasis was applied at tumor supply vessels or subsegmental arteries may indicate the safe use of temporary stasis in some cases where colorectal cancer metastases are treated. Further research is needed to determine the most effective chemoembolization technique.
评估在经导管肝动脉化疗栓塞术(TACE)中使用伊立替康载药微球栓塞结直肠癌(CRC)肝转移灶时,临时阻断(血流停滞)的肝动脉分支水平与并发症和栓塞后综合征(PES)严重程度的相关性。
该研究纳入了 52 例(29 名女性,23 名男性)CRC 肝转移患者,共接受了 202 次载有 100mg 伊立替康的微球 TACE 治疗(平均每位患者 3.88 次)。根据临时阻断的肝动脉分支水平评估 PES 严重程度和并发症发生情况。根据癌症治疗评估计划常见不良事件术语标准评估不良事件。
从 TACE 开始的中位生存时间为 13 个月。在 202 次 TACE 治疗中,发现 15 例(7.4%)严重并发症。研究发现,临时阻断的分支水平与并发症的发生存在显著相关性(<0.001),在节段性血管中观察到的并发症数量最高。在 103 次(51%)TACE 治疗后诊断出 PES。PES 严重程度与临时阻断的分支水平之间存在显著相关性(<0.001)。
临时阻断的分支水平影响 PES 的严重程度。在 TACE 操作中获得的临时阻断的分支水平与并发症的发生存在显著相关性。在肿瘤供血血管或亚节段动脉应用临时阻断时,并发症数量没有明显变化,这表明在某些情况下,安全使用临时阻断治疗结直肠癌转移灶是可行的。需要进一步研究以确定最有效的 TACE 技术。